Human stem cell research and regenerative medicine--present and future
Open Access
- 13 June 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in British Medical Bulletin
- Vol. 99 (1), 155-168
- https://doi.org/10.1093/bmb/ldr027
Abstract
Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of agreement The differentiation ability of all stem cell types could be stimulated to obtain specialized cells that represent renewable sources of functional cells useful for cell-based therapy. Areas of controversy The proof of functional differentiated cells needs to be investigated in more detail using both in vitro and in vivo assays including animal disease models and clinical studies. Growing points Much progress has been made in the ASCs-based therapies. Meanwhile hESCs and iPSCs have dramatically emerged as novel approaches to understand pathogenesis of different diseases. Areas timely for developing research A number of new strategies become very important in regenerative medicine. However, we discuss the limitations of stem cells and latest development in the reprogramming research.Keywords
This publication has 36 references indexed in Scilit:
- EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium SignalingOnline Journal of Public Health Informatics, 2011
- Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes MellitusThe International Journal of Cell Cloning, 2011
- Induced pluripotency: history, mechanisms, and applicationsGenes & Development, 2010
- Bone marrow stem cells and liver regenerationExperimental Hematology, 2010
- Transplanted Oligodendrocytes and Motoneuron Progenitors Generated from Human Embryonic Stem Cells Promote Locomotor Recovery After Spinal Cord TransectionThe International Journal of Cell Cloning, 2010
- Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesisAutoimmunity, 2009
- Fetal stem cells from extra‐embryonic tissues: do not discardJournal of Cellular and Molecular Medicine, 2008
- Immunomodulation of activated hepatic stellate cells by mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Derivation, growth and applications of human embryonic stem cellsReproduction, 2004
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998